Teva Announces Promising Interim Results From Its Study PEARL, About the Impact of AJOVY® (fremanezumab)
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 10 - Classification Committee News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Classification Committee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Classification Committee Today - Breaking & Trending Today
AbbVie Submits Supplemental New Drug Application to U.S. FDA for Atogepant (QULIPTA™) to Support Label Expansion for the Preventive Treatment of Migraine
- Submission is based on pivotal Phase 3 PROGRESS chronic migraine study evaluating atogepant (QULIPTATM) in adult patients that met primary endpoint of...
Source: prnewswire.com
USM looks to adjust pay scales following $15 minimum wage
To address wage compression caused by the University System of Maryland raising its minimum wage to $15, the system is planning to adjust nonexempt staff pay scales. Nonexempt, hourly positions within the USM are sorted into “pay grade” categories that denote the minimum amount that role can be paid, the maximum it can be paid, and ...
Source: thedailyrecord.com
Moawad outlines World Taekwondo plans for more classifiers
World Taekwondo's Classification Committee chair Hadwah Abdelmatloub Moawad has revealed plans to train more classifiers, with the aim of expanding the sport of Para-taekwondo.
Source: insidethegames.biz
AbbVie Announces Positive Phase 3 Atogepant (QULIPTA™) Data for the Preventive Treatment of Chronic Migraine
NORTH CHICAGO, Ill., March 10, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the Phase 3 PROGRESS trial evaluating atogepant (QULI...
Source: businessinsider.com